Nanomagnetic Hyperthermia Sensitizes Gemcitabine Chemosensitivity in Pancreatic Cancer by Inhibiting HSPB1 to Amplify ACSL4‐Mediated Ferroptosis
Small · 2026-04 · 22 (22)
DOI: 10.1002/smll.202514973 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, online erschienen am 22.02.2026. Verfasst von Jiaqiang Ren und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China. Hauptthemen laut MEDLINE: Deoxycytidine, Pancreatic Neoplasms, Ferroptosis, Hyperthermia, Induced. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Generic Technology Research and Development Project of Shaanxi Province, Institutional Foundation of The First Affiliated Hospital of Xi'an Jiaotong University.
Abstract (Originalsprache)
Pancreatic cancer, one of the most malignant solid tumors with the poorest prognosis, is commonly treated with gemcitabine (GEM)‐based systemic chemotherapy. However, chemoresistance remains a significant therapeutic challenge. Ferroptosis, a novel form of programmed cell death, has demonstrated exceptional susceptibility in chemoresistant cancer cells. Due to their unique magnetic responsiveness, iron oxide nanoparticles can generate heat under alternating magnetic fields, which enables magnetic hyperthermia (MH) therapy. This approach not only directly induces tumor cell apoptosis but also enhances chemosensitization. In this study, we demonstrate that ferrimagnetic vortex‐domain iron oxide nanorings (FVIOs) as an ideal nanoplatform for MH, significantly improving GEM chemosensitivity in pancreatic cancer. Both in vitro and in vivo experiments demonstrated that MH not only synergizes with GEM to exhibit an antitumor effect in wild‐type (WT) pancreatic tumors, but also directly suppresses the proliferation of gemcitabine‐resistant (GR) counterparts while alleviating chemoresistance. High‐throughput transcriptomic profiling revealed an increased susceptibility of GR cells to ferroptosis induction. Mechanistically, MH suppressed HSPB1 expression in GR cells, thereby attenuating its regulatory role in the ubiquitination‐mediated degradation of ACSL4 protein and ultimately promoting ferroptosis. Comprehensive in vivo evaluations confirmed the multidimensional chemosensitizing efficacy of MH alongside favorable biosafety. Our findings highlight MH as a promising adjuvant strategy for pancreatic cancer, particularly in GEM‐resistant cases, by overcoming chemoresistance through the potentiation of ferroptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, Shaanxi, China.
- School of Future Technology, Xi'an Jiaotong University, Xi'an, Shaanxi, China.
- Department of General Surgery, The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shaanxi, China.
ORCID-Profile: Zheng Wu
Förderung
- National Natural Science Foundation of China
- Generic Technology Research and Development Project of Shaanxi Province
- Institutional Foundation of The First Affiliated Hospital of Xi'an Jiaotong University
- Clinical research project of the First Affiliated Hospital of Xi'an Jiaotong University
Zitieren
APA
Ren, J., Wu, S., Su, T., Li, H., Ding, J., Chen, F., Mo, J., Li, J., Wang, Z., Han, L., & Wu, Z. (2026). Nanomagnetic Hyperthermia Sensitizes Gemcitabine Chemosensitivity in Pancreatic Cancer by Inhibiting HSPB1 to Amplify ACSL4‐Mediated Ferroptosis. Small, 22(22). https://doi.org/10.1002/smll.202514973
Vancouver
Ren J, Wu S, Su T, Li H, Ding J, Chen F, et al. Nanomagnetic Hyperthermia Sensitizes Gemcitabine Chemosensitivity in Pancreatic Cancer by Inhibiting HSPB1 to Amplify ACSL4‐Mediated Ferroptosis. Small. 2026;22(22). doi:10.1002/smll.202514973
BibTeX
@article{Ren2026,
author = {Ren, Jiaqiang and Wu, Shuai and Su, Tong and Li, Hugang and Ding, Jiachun and Chen, Fan and Mo, Jiantao and Li, Jie and Wang, Zheng and Han, Liang and Wu, Zheng},
title = {Nanomagnetic Hyperthermia Sensitizes Gemcitabine Chemosensitivity in Pancreatic Cancer by Inhibiting HSPB1 to Amplify ACSL4‐Mediated Ferroptosis},
journal = {Small},
year = {2026},
volume = {22},
number = {22},
doi = {10.1002/smll.202514973}
}
EUVIMED